The Institute of Bioengineering and Bioimaging (IBB) spearheads multi-disciplinary, application-driven research at the interface of biology, chemistry, engineering, imaging, artificial intelligence, and medicine, with a focus on translation and real-world impact.The institute’s research activities are focused in three main areas:1. Biomedical Devices & Diagnostics2. Bioengineering Systems3. Biophotonics & BioimagingWHAT WE HAVE TO OFFERIBB is industry-ready and committed to providing high quality bioengineering and bioimaging technologies to government, clinical and industrial partners, leveraging on its human capital of over 130 bioengineers, imaging experts, biologists, chemists, physicists, as well as clinicians and state-of-the-art bioengineering and bioimaging research facilities (laboratories / instrumentations). IBB scientists have an excellent track record of methodological and instrumental development both intramurally and in association with academic, clinical and industrial partners, delivering innovative solutions in strategic areas of national priority such as cancer, infectious diseases, metabolic/cardio-vascular disorders, neuronal/psychiatric dysfunctions, and food & nutrition.
IBB’S KEY CAPABILITIES
17 A*STAR researchers are recognised as the world's most influential scientific minds in 2022. Find out more about their work and what drives them to push the frontiers of scientific excellence! A*STAR’s Highly Cited Researchers of 2022